Logo image of CGC

CANOPY GROWTH CORP (CGC) Stock Price, Forecast & Analysis

USA - NASDAQ:CGC - CA1380357048 - Common Stock

1.07 USD
+0.02 (+1.9%)
Last: 11/18/2025, 8:00:00 PM
1.08 USD
+0.01 (+0.93%)
Pre-Market: 11/19/2025, 4:22:48 AM

CGC Key Statistics, Chart & Performance

Key Statistics
Market Cap361.93M
Revenue(TTM)278.61M
Net Income(TTM)-385.85M
Shares338.25M
Float311.42M
52 Week High4.25
52 Week Low0.77
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-2.01
PEN/A
Fwd PEN/A
Earnings (Next)02-05 2026-02-05/bmo
IPO2010-06-04
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


CGC short term performance overview.The bars show the price performance of CGC in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40

CGC long term performance overview.The bars show the price performance of CGC in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of CGC is 1.07 USD. In the past month the price decreased by -21.9%. In the past year, price decreased by -72.56%.

CANOPY GROWTH CORP / CGC Daily stock chart

CGC Latest News, Press Relases and Analysis

CGC Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 46.84 974.90B
JNJ JOHNSON & JOHNSON 19.27 481.67B
MRK MERCK & CO. INC. 10.95 240.86B
PFE PFIZER INC 7.95 144.70B
BMY BRISTOL-MYERS SQUIBB CO 7.17 95.79B
ZTS ZOETIS INC 18.63 52.36B
RPRX ROYALTY PHARMA PLC- CL A 9.6 23.01B
VTRS VIATRIS INC 4.6 12.49B
ELAN ELANCO ANIMAL HEALTH INC 22.28 10.63B
CORT CORCEPT THERAPEUTICS INC 85.35 7.91B
AXSM AXSOME THERAPEUTICS INC N/A 7.36B
BLTE BELITE BIO INC - ADR N/A 4.30B

About CGC

Company Profile

CGC logo image Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The company is headquartered in Smiths Falls, Ontario and currently employs 960 full-time employees. The company went IPO on 2010-06-04. The company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.

Company Info

CANOPY GROWTH CORP

1 Hershey Dr

Smiths Falls ONTARIO K7A0A8 CA

CEO: David Klein

Employees: 960

CGC Company Website

CGC Investor Relations

Phone: 18555589333

CANOPY GROWTH CORP / CGC FAQ

Can you describe the business of CANOPY GROWTH CORP?

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The company is headquartered in Smiths Falls, Ontario and currently employs 960 full-time employees. The company went IPO on 2010-06-04. The company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


Can you provide the latest stock price for CANOPY GROWTH CORP?

The current stock price of CGC is 1.07 USD. The price increased by 1.9% in the last trading session.


Does CANOPY GROWTH CORP pay dividends?

CGC does not pay a dividend.


What is the ChartMill technical and fundamental rating of CGC stock?

CGC has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Which stock exchange lists CGC stock?

CGC stock is listed on the Nasdaq exchange.


What is CANOPY GROWTH CORP worth?

CANOPY GROWTH CORP (CGC) has a market capitalization of 361.93M USD. This makes CGC a Small Cap stock.


What is the outstanding short interest for CANOPY GROWTH CORP?

The outstanding short interest for CANOPY GROWTH CORP (CGC) is 12.09% of its float.


CGC Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

CGC Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to CGC. The financial health of CGC is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CGC Financial Highlights

Over the last trailing twelve months CGC reported a non-GAAP Earnings per Share(EPS) of -2.01. The EPS increased by 58.19% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -36.07%
ROE -52.42%
Debt/Equity 0.33
Chartmill High Growth Momentum
EPS Q2Q%99.05%
Sales Q2Q%8.47%
EPS 1Y (TTM)58.19%
Revenue 1Y (TTM)-0.67%

CGC Forecast & Estimates

13 analysts have analysed CGC and the average price target is 2.68 USD. This implies a price increase of 150.1% is expected in the next year compared to the current price of 1.07.

For the next year, analysts expect an EPS growth of 88.6% and a revenue growth 8.32% for CGC


Analysts
Analysts46.15
Price Target2.68 (150.47%)
EPS Next Y88.6%
Revenue Next Year8.32%

CGC Ownership

Ownership
Inst Owners5.58%
Ins Owners0.13%
Short Float %12.09%
Short Ratio1.63